The DRAIGON Consortium launched its website!
The project's objective is to create a cutting-edge in vitro diagnostic device (IVD) that combines artificial intelligence (AI) with whole-genome sequencing (WGS) for the rapid and accurate diagnosis of patients infected multi-drug resistance (MDR) microorganisms and to reduce the prevalence of antimicrobial resistance (AMR).
DRAIGON Consortium is a collaborative initiative supported by key partners including the European Vaccine Initiative (EVI), UMCG research, CAMTECH, Orthopädisches Spital Speising, Health-Ecore, Isala (ziekenhuis), The Johns Hopkins University, Sandoz, and Spitali Universitar Shefqet Ndroqi. This website's launch is part of Draigon's larger effort to foster better communication and cooperation by creating and providing access to cutting-edge research and technology.
Read more about the project at DRAIGON Consortium’s website https://www.draigon.eu/
PROJECT COORDINATOR
CONTACT
Adriana Vives
European Vaccine Initiative (EVI) - Project Manager
Email: adriana.vives@euvaccine.eu
PROJECT COORDINATOR
The European Vaccine Initiative (EVI) (Germany)
Comments